296 related articles for article (PubMed ID: 15278371)
1. No effect on adenoma formation in Min mice after moderate amount of flaxseed.
Oikarinen S; Heinonen SM; Nurmi T; Adlercreutz H; Mutanen M
Eur J Nutr; 2005 Aug; 44(5):273-80. PubMed ID: 15278371
[TBL] [Abstract][Full Text] [Related]
2. Effects of a flaxseed mixture and plant oils rich in alpha-linolenic acid on the adenoma formation in multiple intestinal neoplasia (Min) mice.
Oikarinen SI; Pajari AM; Salminen I; Heinonen SM; Adlercreutz H; Mutanen M
Br J Nutr; 2005 Oct; 94(4):510-8. PubMed ID: 16197574
[TBL] [Abstract][Full Text] [Related]
3. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice.
van Kranen HJ; Mortensen A; Sørensen IK; van den Berg-Wijnands J; Beems R; Nurmi T; Adlercreutz H; van Kreijl CF
Nutr Cancer; 2003; 45(2):203-10. PubMed ID: 12881015
[TBL] [Abstract][Full Text] [Related]
4. Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model.
Aura AM; Oikarinen S; Mutanen M; Heinonen SM; Adlercreutz HC; Virtanen H; Poutanen KS
Eur J Nutr; 2006 Feb; 45(1):45-51. PubMed ID: 15864408
[TBL] [Abstract][Full Text] [Related]
5. Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions.
Oikarinen S; Heinonen S; Karppinen S; Mättö J; Adlercreutz H; Poutanen K; Mutanen M
Br J Nutr; 2003 Jul; 90(1):119-25. PubMed ID: 12844383
[TBL] [Abstract][Full Text] [Related]
6. [Phytoestrogenis properties of flaxseed lignans].
Martinchik AN; Zubtsov VV
Vopr Pitan; 2012; 81(6):61-6. PubMed ID: 23530438
[TBL] [Abstract][Full Text] [Related]
7. Human metabolism of mammalian lignan precursors in raw and processed flaxseed.
Nesbitt PD; Lam Y; Thompson LU
Am J Clin Nutr; 1999 Mar; 69(3):549-55. PubMed ID: 10075344
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
Mukker JK; Singh RS; Muir AD; Krol ES; Alcorn J
Br J Nutr; 2015 Mar; 113(5):749-57. PubMed ID: 25716060
[TBL] [Abstract][Full Text] [Related]
9. Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats.
Ward WE; Yuan YV; Cheung AM; Thompson LU
J Toxicol Environ Health A; 2001 May; 63(1):53-65. PubMed ID: 11346133
[TBL] [Abstract][Full Text] [Related]
10. The anti-cancer effect of flaxseed lignan derivatives on different acute myeloid leukemia cancer cells.
Tannous S; Haykal T; Dhaini J; Hodroj MH; Rizk S
Biomed Pharmacother; 2020 Dec; 132():110884. PubMed ID: 33080470
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary flaxseed on intestinal tumorigenesis in Apc(Min) mouse.
Bommareddy A; Zhang X; Schrader D; Kaushik RS; Zeman D; Matthees DP; Dwivedi C
Nutr Cancer; 2009; 61(2):276-83. PubMed ID: 19235044
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed.
Rickard SE; Orcheson LJ; Seidl MM; Luyengi L; Fong HH; Thompson LU
J Nutr; 1996 Aug; 126(8):2012-9. PubMed ID: 8759374
[TBL] [Abstract][Full Text] [Related]
13. Personalized Nutrition Using Microbial Metabolite Phenotype to Stratify Participants and Non-Invasive Host Exfoliomics Reveal the Effects of Flaxseed Lignan Supplementation in a Placebo-Controlled Crossover Trial.
Mullens DA; Ivanov I; Hullar MAJ; Randolph TW; Lampe JW; Chapkin RS
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745107
[TBL] [Abstract][Full Text] [Related]
14. Influence of Flaxseed Lignan Supplementation to Older Adults on Biochemical and Functional Outcome Measures of Inflammation.
Di Y; Jones J; Mansell K; Whiting S; Fowler S; Thorpe L; Billinsky J; Viveky N; Cheng PC; Almousa A; Hadjistavropoulos T; Alcorn J
J Am Coll Nutr; 2017; 36(8):646-653. PubMed ID: 28922068
[TBL] [Abstract][Full Text] [Related]
15. Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans.
Lampe JW; Kim E; Levy L; Davidson LA; Goldsby JS; Miles FL; Navarro SL; Randolph TW; Zhao N; Ivanov I; Kaz AM; Damman C; Hockenbery DM; Hullar MAJ; Chapkin RS
Am J Clin Nutr; 2019 Aug; 110(2):377-390. PubMed ID: 31175806
[TBL] [Abstract][Full Text] [Related]
16. A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women.
Hallund J; Ravn-Haren G; Bügel S; Tholstrup T; Tetens I
J Nutr; 2006 Jan; 136(1):112-6. PubMed ID: 16365068
[TBL] [Abstract][Full Text] [Related]
17. The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1.
Ren GY; Chen CY; Chen WG; Huang Y; Qin LQ; Chen LH
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1303-1310. PubMed ID: 27849354
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of plant lignans for the formation of enterolactone in vivo.
Saarinen NM; Smeds A; Mäkelä SI; Ammälä J; Hakala K; Pihlava JM; Ryhänen EL; Sjöholm R; Santti R
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):311-9. PubMed ID: 12270222
[TBL] [Abstract][Full Text] [Related]
19. Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring.
Ward WE; Chen J; Thompson LU
J Toxicol Environ Health A; 2001 Dec; 64(7):567-77. PubMed ID: 11760154
[TBL] [Abstract][Full Text] [Related]
20. The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth.
Bowers LW; Lineberger CG; Ford NA; Rossi EL; Punjala A; Camp KK; Kimler BK; Fabian CJ; Hursting SD
Breast Cancer Res Treat; 2019 Feb; 173(3):545-557. PubMed ID: 30367332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
